The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Relapse-specific mutations in cytosolic 5’-nucleotidase II in childhood acute lymphoblastic leukemia.
Julia Meyer
No relevant relationships to disclose
Jinhua Wang
No relevant relationships to disclose
Laura E. Hogan
No relevant relationships to disclose
Jay Patel
No relevant relationships to disclose
Zuojian Tang
No relevant relationships to disclose
Paul Zumbo
No relevant relationships to disclose
Sheng Li
No relevant relationships to disclose
Jiri Zavadil
No relevant relationships to disclose
Ross L. Levine
No relevant relationships to disclose
Timothy Cardozo
No relevant relationships to disclose
Stephen Hunger
No relevant relationships to disclose
Elizabeth A. Raetz
No relevant relationships to disclose
Debra J. Morrison
No relevant relationships to disclose
Christopher Mason
No relevant relationships to disclose
William L. Carroll
No relevant relationships to disclose